Trending Now

Fortune Post Healthcare

Healthcare News

Menu
Follow Us:
Search
Flash Story
Private Equity Investments In Healthcare Raises Costs: Study
Private Equity Investments In Healthcare Raises Costs: Study
EU Regulator Declines To Support Mirati's Lung Cancer Drug
EU Regulator Declines To Support Mirati’s Lung Cancer Drug
HIV Drug Resistance Mechanisms Revealed By Protein Structures: Study
HIV Drug Resistance Mechanisms Revealed By Protein Structures: Study
Gambia To Explore Legal Action On Maiden Pharma Over Toxic Cough Syrup
Gambia To Explore Legal Action On Maiden Pharma Over Toxic Cough Syrup
Annual Profit Forecast Raised By J&J On Medical Devices, Cancer Drugs Strength
Annual Profit Forecast Raised By J&J On Medical Devices, Cancer Drugs Strength
Lupin Gets Tentative Approval From USFDA For Hepatitis Drugs & HIV
Lupin Gets Tentative Approval From USFDA For Hepatitis Drugs & HIV
WHO Warned On Dengue Risk For Global Warming Impact
WHO Warned On Dengue Risk For Global Warming Impact
Govt. Says Over 2 Lakh Calls Received On Tele-Manas Since Its Launch
Govt. Says Over 2 Lakh Calls Received On Tele-Manas Since Its Launch
Are You Consuming Enough Niacin? Add These Superfoods To Your Diet

Tag: Cancer Drugs Strength

Healthcare
healthcare

Annual Profit Forecast Raised By J&J On Medical Devices, Cancer Drugs Strength

Annual Profit Forecast Raised By J&J On Medical Devices, Cancer Drugs Strength J&J’s top-selling drug, Stelara, which is going off patent, is expected to face competition from cheaper copies in 2025, and the company has been leaning on newer drugs such as cancer therapy Carvykti to replace a potential loss in sales. Johnson & Johnson raised […]

Back To Top